MindBio Therapeutics Corp. (CSE:MBIO)

MindBio Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	0.08	0.14	0.32	1.31
Short-Term Investments	-	-	0.01	0.03
Cash & Short-Term Investments	0.08	0.14	0.33	1.35
Cash Growth	-35.65%	-58.48%	-75.22%	-
Other Receivables	0.07	0.06	0.05	0.05
Receivables	0.07	0.06	0.05	0.05
Restricted Cash	-	-	0.28	0.22
Total Current Assets	0.14	0.19	0.67	1.61
Total Assets	0.14	0.19	0.67	1.61
Accounts Payable	0.66	0.53	0.57	0.05
Accrued Expenses	0.08	0.08	0.08	1.15
Current Portion of Long-Term Debt	5.05	5.02	2.16	-
Current Unearned Revenue	-	-	0.12	-
Total Current Liabilities	5.79	5.63	2.93	1.19
Long-Term Debt	-	-	2.82	4.5
Other Long-Term Liabilities	0.31	0.31	0.35	0.15
Total Liabilities	6.1	5.94	6.09	5.84
Common Stock	5.7	5.48	5.37	4.51
Retained Earnings	-13.18	-12.76	-12.38	-8.74
Comprehensive Income & Other	1.57	1.58	1.65	-
Total Common Equity	-5.9	-5.69	-5.36	-4.23
Minority Interest	-0.06	-0.05	-0.06	-
Shareholders' Equity	-5.96	-5.74	-5.42	-4.23
Total Liabilities & Equity	0.14	0.19	0.67	1.61
Total Debt	5.05	5.02	4.97	4.5
Net Cash (Debt)	-4.97	-4.88	-4.64	-3.15
Net Cash Per Share	-0.03	-0.04	-0.04	-0.06
Filing Date Shares Outstanding	142.96	135.05	133.05	53.43
Total Common Shares Outstanding	142.96	135.05	133.05	53.43
Working Capital	-5.65	-5.43	-2.25	0.42
Book Value Per Share	-0.04	-0.04	-0.04	-0.08
Tangible Book Value	-5.9	-5.69	-5.36	-4.23
Tangible Book Value Per Share	-0.04	-0.04	-0.04	-0.08

Source: S&P Capital IQ. Standard template. Financial Sources.